dc.creator | Jiménez Rodríguez, Rosa M. | es |
dc.creator | Martos Martínez, Juan Manuel | es |
dc.creator | Capitan-Morales, Luis-Cristobal | es |
dc.creator | Pareja Ciuró, Felipe | es |
dc.creator | Gómez Rosado, Juan Carlos | es |
dc.creator | Tallón Aguilar, Luis | es |
dc.date.accessioned | 2022-11-16T14:25:16Z | |
dc.date.available | 2022-11-16T14:25:16Z | |
dc.date.issued | 2021-06 | |
dc.identifier.citation | Jiménez Rodríguez, R.M., Martos Martínez, J.M., Capitan-Morales, L., Pareja Ciuró, F., Gómez Rosado, J.C. y Tallón Aguilar, L. (2021). Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study. Anaesthesia, 76 (6), 748-758. https://doi.org/10.1111/anae.15458. | |
dc.identifier.issn | 0003-2409;1365-2044 | es |
dc.identifier.uri | https://hdl.handle.net/11441/139511 | |
dc.description.abstract | Peri-operative SARS-CoV-2 infection increases postoperative mortality. The aim of this study was to determine the optimal duration of planned delay before surgery in patients who have had SARS-CoV-2 infection. This international, multicentre, prospective cohort study included patients undergoing elective or emergency surgery during October 2020. Surgical patients with pre-operative SARS-CoV-2 infection were compared with those without previous SARS-CoV-2 infection. The primary outcome measure was 30-day postoperative mortality. Logistic regression models were used to calculate adjusted 30-day mortality rates stratified by time from diagnosis of SARS-CoV-2 infection to surgery. Among 140,231 patients (116 countries), 3127 patients (2.2%) had a pre-operative SARS-CoV-2 diagnosis. Adjusted 30-day mortality in patients without SARS-CoV-2 infection was 1.5% (95%CI 1.4–1.5). In patients with a pre-operative SARS-CoV-2 diagnosis, mortality was increased in patients having surgery within 0–2 weeks, 3–4 weeks and 5–6 weeks of the diagnosis (odds ratio (95%CI) 4.1 (3.3–4.8), 3.9 (2.6–5.1) and 3.6 (2.0–5.2), respectively). Surgery performed ≥ 7 weeks after SARS-CoV-2 diagnosis was associated with a similar mortality risk to baseline (odds ratio (95%CI) 1.5 (0.9–2.1)). After a ≥ 7 week delay in undertaking surgery following SARS-CoV-2 infection, patients with ongoing symptoms had a higher mortality than patients whose symptoms had resolved or who had been asymptomatic (6.0% (95%CI 3.2–8.7) vs. 2.4% (95%CI 1.4–3.4) vs. 1.3% (95%CI 0.6–2.0), respectively). Where possible, surgery should be delayed for at least 7 weeks following SARS-CoV-2 infection. Patients with ongoing symptoms ≥ 7 weeks from diagnosis may benefit from further delay. | es |
dc.format | application/pdf | es |
dc.format.extent | 11 p. | es |
dc.language.iso | eng | es |
dc.publisher | Wiley-Blackwell | es |
dc.relation.ispartof | Anaesthesia, 76 (6), 748-758. | |
dc.rights | Atribución-NoComercial 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | * |
dc.title | Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study | es |
dc.type | info:eu-repo/semantics/article | es |
dcterms.identifier | https://ror.org/03yxnpp24 | |
dc.type.version | info:eu-repo/semantics/publishedVersion | es |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | es |
dc.contributor.affiliation | Universidad de Sevilla. Departamento de Cirugía | es |
dc.relation.publisherversion | https://associationofanaesthetists-publications.onlinelibrary.wiley.com/doi/10.1111/anae.15458 | es |
dc.identifier.doi | 10.1111/anae.15458 | es |
dc.journaltitle | Anaesthesia | es |
dc.publication.volumen | 76 | es |
dc.publication.issue | 6 | es |
dc.publication.initialPage | 748 | es |
dc.publication.endPage | 758 | es |